[ET Net News Agency, 13 January 2022] Hangzhou Tigermed Consulting Co., Ltd. (03347)
said for the year of 2021, its net profit attributable to shareholders of the company is
expected to be RMB2,624,662,200 to RMB3,027,110,400, a 50% to 73% growth compared with the
same period of last year.
During the reporting period, the company's main business continued to grow. (RC)